Transcriptional Profiling of Formalin Fixed Paraffin Embedded Tissue: Pitfalls and Recommendations for Identifying Biologically Relevant Changes by Rentoft, Matilda et al.
Transcriptional Profiling of Formalin Fixed Paraffin
Embedded Tissue: Pitfalls and Recommendations for
Identifying Biologically Relevant Changes
Matilda Rentoft
1*, Philip John Coates
2,G o ¨ran Laurell
3, Karin Nylander
1
1Department of Medical Biosciences/Pathology, Umea ˚ University, Umea ˚, Sweden, 2Tayside Tissue Bank, Medical Research Institute, Ninewells Hospital and Medical
School, University of Dundee, Dundee, United Kingdom, 3Department of Clinical Sciences/Otorhinolaryngology, Norrlands University Hospital, Umea ˚, Sweden
Abstract
Expression profiling techniques have been used to study the biology of many types of cancer but have been limited to
some extent by the requirement for collection of fresh tissue. In contrast, formalin fixed paraffin embedded (FFPE) samples
are widely available and represent a vast resource of potential material. The techniques used to handle the degraded and
modified RNA from these samples are relatively new and all the pitfalls and limitations of this material for whole genome
expression profiling are not yet clarified. Here, we analyzed 70 FFPE tongue carcinoma samples and 17 controls using the
whole genome DASL array covering nearly 21000 genes. We identified that sample age is related to quality of extracted RNA
and that sample quality influences apparent expression levels in a non-random manner related to gene probe sequence,
leading to spurious results. However, by removing sub-standard samples and analysing only those 28 cancers and 15
controls that had similar quality we were able to generate a list of 934 genes significantly altered in tongue cancer
compared to control samples of tongue. This list contained previously identified changes and was enriched for genes
involved in many cancer-related processes such as tissue remodelling, inflammation, differentiation and apoptosis. Four
novel genes of potential importance in tongue cancer development and maintenance, SH3BGL2, SLC2A6, SLC16A3 and
CXCL10, were independently confirmed, validating our data. Hence, gene expression profiling can be performed usefully on
archival material if appropriate quality assurance steps are taken to ensure sample consistency and we present some
recommendations for the use of FFPE material based on our findings.
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Introduction
Transcriptional profiling by DNA microarray analysis is proving
to be a powerful tool in cancer research, significantly increasing
our knowledge of tumour development and progression. It has also
provided novel treatment targets and prediction models for
prognosis and treatment response [1–4]. An obstacle to the
widespread use of expression profiling has been the limited
availability of fresh frozen (FF) samples from which high quality
RNA can be extracted [3]. This becomes particularly important
when attempting to discover differences associated with individual
sub-types of cancer. For example, although approximately 350
cases of cancer in the oral cavity are diagnosed in Sweden every
year, there is an increasing awareness that tumours of different
locations within the oral region are not comparable, having
different clinical presentations and outcomes and being associated
with distinct risk factors and genetic changes [5–10]. Thus, the
number of fresh samples from individual sub-sites becomes rather
limited.
Recent developments have opened up new opportunities to
analyze partially degraded RNA from formalin fixed paraffin
embedded (FFPE) samples, the standard method for preserving
tissue and for which millions of patient samples are stored around
the world [11–14]. The focused DASL array targeting 502 cancer
related genes was the first microarray provided by Illumina
designed to handle partially degraded RNA [13]. This array has
been successfully used in two studies on oral cavity tumours, one
focusing on tongue and the other on buccal mucosa [15,16]. The
results of these analyses provided a high degree of consistency of
identified genes [17], which may relate to the focused nature of the
interrogated set of genes for general cancer changes. However,
identifying site-specific changes in gene expression requires the
ability to profile a larger set of genes including those with specific
rather than general actions in cancer. The focused array has
recently been expanded into a whole genome (WG) array covering
20818 genes [14] and has so far been utilized in a handful of
studies on FFPE material, primarily on breast tissue [18–20]. One
study on oral cancer tissue using the WG-DASL array has been
performed comparing tumours with different invasive patterns
using formalin fixed and paraffin embedded fresh frozen samples
from which RNA was extracted within 24 hours of fixation [21].
Here we analysed FFPE samples from 70 patients with
squamous cell carcinoma (SCC) of the tongue that had been
stored between 1 and 13 years and evaluated performance of the
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appropriate set-up for an efficient and accurate differential
expression analysis and found 934 genes with altered expression
in tumours. To our knowledge we are the first to analyse whole
genome gene expression patterns in a large number of FFPE SCC
tongue samples that have been archived over a longer period of
time, opening up this approach for additional studies into the
pathobiology of oral cancer in individual sites and the identifica-
tion of additional biomarkers.
Methods
Sample characteristics and RNA extraction
FFPE blocks from 70 patients with squamous cell carcinoma
(SCC) of the moveable tongue between 1997 and 2010 were
available for analysis. Patient age varied from 19 to 88 years (mean
58 years). Fifty patients had a T1 or T2 tumour while the
remaining 20 patients had a T3 or T4 tumour. Twenty patients
had cervical nodal spread at diagnosis. The male to female ratio
was 1.3:1. Seventeen control samples were derived from patients
with non-malignant changes on the tongue. The mean age was 49
years and the male to female ratio 1.1:1 in the control group.
Average age and stage distributions in the 28 SCC samples
selected for differential gene expression analysis were similar to the
whole group but the proportion of women was increased (1:1.3).
Ten 5 mm sections were collected from each of the 87 FFPE
samples and RNA extracted immediately using the high pure
RNA extraction kit (Roche Diagnostics GmbH). RNA was eluted
in 40 ml elution buffer and a total of 400 ng RNA was needed for
pre-qualification and array analysis. Ten paired fresh frozen (FF)
samples derived from patients with tongue SCC and adjacent
clinically normal oral mucosa were available for qPCR confirma-
tion and RNA was extracted using the trizole method. FF samples
came from eight men and two women, all but one had T1 or T2
tumours and average age was 67 years. All RNA samples were
stored at 280uC until further use. The study was approved by the
local ethical review committee ‘‘Etik Provnings Namnden’’ (EPN),
Permit number 08-003 M. For the FF samples written consent was
obtained from all patients. For the archival FFPE samples written
consent is available for samples from 2003 and onwards because of
the establishment of the Swedish Act on Biobanks (SF 2002:297).
The use of FFPE samples dated before 2003 was approved by the
local ethical review committee (EPN) according to their standard
procedure. All samples came from Biobank VL (Vasterbottens
Lan).
Quality measurement and confirmation using qPCR
analysis
cDNA reactions were performed using RevertAid H minus first
strand cDNA kit (Fermentas) with 200 ng input RNA. For qPCR
quality assessment of RNA from FFPE samples the expression of
TUBA6, previously shown to be stably expressed in oral tissue
[22], was analysed in all FFPE samples as well as two normal FF
samples using IQ SYBR green supermix (BioRad) according to the
manufacturer’s instructions. Quality measurement of the samples
(Ctdiff) was defined as the difference in cycles taken to reach the
threshold for the FFPE sample compared to the two FF samples
(average) (Ctdiff=Ct FFPE2CtFF). A difference of more than twelve
cycles between the two tissues was set as a cut-off for inadequate
RNA quality based on Illumina recommendations. qPCR
confirmation of four selected genes was performed using the
quanti tect primer assay together with the quanti tect SYBR green
assay (Qiagen). Expression levels of the four genes were evaluated
in ten of the FFPE samples for which sufficient RNA was available
and the ten paired FF samples.
Array hybridisation and analysis
The DASL assay was performed as previously described [15]
with the exception that the WG DASL pool of oligonucleotides
was used (containing 29377 probes, covering 20818 genes) and the
PCR products precipitated and hybridized to BeadChips instead
of the sentrix universal Array Matrix (Illumina). Samples were
evenly spread over eight BeadChips which could hold twelve
samples each and all samples were run at the same occasion. The
BeadArray Reader 500 was used to scan the arrays, and image
analysis performed using GenomStudio (Illumina). The average
signal and the 95
th percentile of the probe intensities (p95) were
used to evaluate the quality of the hybridisation. Average signal
intensity .500 and a p95 .2500 were judged as acceptable.
Several hundred negative control probes were included on the
arrays for calculations of detection p-values. Genes significantly
detected in either controls or tumours with a p,0.01 were
included in the analysis. Raw data were normalized using cubic
spline algorithm without background normalization and used in all
analyses if not otherwise stated. Array data have been submitted to
and are available from the gene expression omnibus (GEO)
(accession number GSE34115). The experimental procedure is
summarized in a flowchart in Figure 1.
Statistics
Replicate reproducibility was analysed using simple linear
regression and the coefficient of determination (R
2) and p-values
are presented. Linear regression analysis was also used to
investigate factors influencing the quality of the sample, the
number of genes detected on the array (i.e. genes with expression
levels significantly above background; p,0.01) and the expression
level of individual genes. All regression models only included
tumour samples to avoid the large variation caused by the many
differentially expressed genes between control and tumour
samples. Comparison of quality measurements between tumours
and controls and evaluation of qPCR results and sequence
differences was performed in SPSS using the appropriate statistical
test, as denoted in each figure, and significance was set to p,0.05.
Since normality could not be assumed, non-parametric tests were
used. Mann-Whitney U-test was used for unpaired samples and
Wilcoxon matched pairs signed rank test was used for paired
samples. Sequence analysis was performed on probe level while all
other analyses were performed at the gene level. When selecting
the 10 probes least affected by sample quality, an additional
restriction was included, that the gene should be expressed at least
46background in all samples, to exclude genes that were not
recognised as affected because they were close to the detection
limit. Differential gene expression analysis was performed using
GenomeStudio provided by Illumina. P values were corrected for
multiple testing using Benjamini-Hochberg and the significance
level set to p,0.01 to increase stringency. Unsupervised clustering
of samples was performed using Pearson correlation as the
measurement of similarity. Pathway analysis of genes significantly
changed in tumours was carried out using GeneGo.
Results
Sample and array performance
RNA for microarray analysis was extracted from 70 tongue
carcinoma samples and 17 controls. Four tumours provided less
than 400 ng total RNA and could not be analyzed further
(figure 1). The remaining 66 tumour samples gave on average
Transcriptional Profiling of FFPE Tissue
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consistently lower amounts (1.8 mg, p=0.01) (Table 1).
The quality of RNA from the FFPE samples was evaluated
according to Illumina recommendations by comparing how well
they amplified a house-keeping gene using q-PCR compared to
RNA from fresh frozen (FF) tissue (Ctdiff=Ct FFPE2CtFF). One
sample failed the PCR reaction while all other FFPE samples
reached the threshold between 1–10.7 cycles later than FF tissue,
which is within the acceptable level (Table 1). A significant
relationship between month in storage and Ctdiff was identified
using linear regression analysis explaining approximately 33% of
the variation (r
2=0.33, p,0.001) (Figure 2).
Eighty three unique samples and two replicate samples were
hybridized to the arrays, including the sample that failed the PCR
reaction. One of the two replicates was placed on the same chip as
its counterpart and the other placed on a separate chip to evaluate
differences in reproducibility within and between chips. Both
replicates showed high correlation (r
2=0.97 and r
2=0.98
respectively). The success rate of the arrays was high and more
than 95% passed the quality control. However, five samples,
including the sample that failed in the PCR reaction and one
control sample, had an average signal intensity ,500 and a p95
,2500 and were thus excluded from further analysis, leaving 78
samples (Figure 1). On average, 52% of the genes on the array
could be detected. In general, control samples performed better
than tumours, with significantly lower Ctdiff and higher average
signal, p95 and number of detected genes. Data for RNA and
array quality measurements are summarised in table 1. The
number of genes detected in each sample varied and linear
regression showed that this could be explained largely by the
quality of the samples measured by Ctdiff (r
2=0.71, p,0.001)
Figure 1. Flowchart illustrating experimental procedure. De-
scription of the procedures used to assess samples from RNA extraction
to acquiring of gene lists, including samples removed following each
step of analysis. Tumour samples are abbreviated T and controls C.
doi:10.1371/journal.pone.0035276.g001
Table 1. Quality measurements of FFPE controls and
tumours.
Group n Average STDEV p-value
a
RNA (mg) C 17 1.8 1.6 0.01
T6 6
b 3.7 3.4
Ct diff C 17 3.5 3.3 0.002
T6 5
c 5.2 2.2
Mean signal C 16
d 1485 421 0.03
T6 2
d 1227 359
p95 C 16 8020 2101 0.06
T 62 6801 1976
Detected genes C 16 11836 1879 0.02
T 62 10558 2186
aMann-Whitney U test.
b4 samples did not generate sufficient RNA (,40 ong).
c1 sample failed the PCR reaction.
d4 tumours and 1 control failed to fulfil array requirements.
doi:10.1371/journal.pone.0035276.t001
Figure 2. Linear regression analysis. Regression model describing
how much of the variation in sample quality (Ctdiff) can be explained by
sample storage time prior to extraction.
doi:10.1371/journal.pone.0035276.g002
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the number of genes detected (r
2=0.36, P,0.001) but multivar-
iate linear regression indicated that this factor provided very little
unique information beyond the contribution of Ctdiff. Taken
together, a strong linear relationship between quality of the RNA
and the performance of the arrays was observed. The effect of
reduced sample quality therefore leads to a decrease in the average
signal intensity of the array and progressively increases the number
of genes whose signal intensities fall to background levels, where an
increase of one cycle in Ctdiff leads to approximately 880
additional genes being classified as not-detected in the poorer
quality sample.
The influence of sample quality on individual genes
To investigate how the expression level of individual genes was
affected by sample quality a linear regression analysis was
performed on each gene detected on the array, asking the
question if Ctdiff significantly influenced its’ expression level. Using
non-normalized array data, expression of 60% of the genes was
significantly influenced by sample quality. Normalizing data using
any of the three methods provided in the Illumina software
GenomeStudio at best decreased the number of affected genes to
55%. For non-normalized data, the expression of the majority of
the affected genes decreased with a decrease in Ctdiff, as noted
above. In addition, a small percentage (1.8%) of genes had an
increased expression with a decrease in quality. Small RNAs,
including small nucleolar RNAs (snoRNA) and microRNAs
(miRNA), were highly over-represented among those genes. In
general, fewer small RNAs were significantly associated to sample
quality (32%) and of these 78% showed increased expression with
a decrease in sample quality. Figure 4 shows an example of three
genes, one whose expression level decreased with a ten cycle
change in Ctdiff (YPEL5), one that was not influenced by sample
quality (TRPM4) and one that had an increased expression with a
ten cycle change in Ctdiff (SNORA10). The same trend was seen
both in control and tumour samples and did not change after
normalization.
Importance of probe sequence for gene expression level
The sequence of the probe could give clues to why there is a
difference in how individual genes are affected by sample quality
[11,19]. Comparing the probe sequence of the ten genes that were
influenced by sample quality with the highest significance to the
ten least affected genes, the total number of Guanines was higher
and the total number of Cytosines was lower in the affected genes.
In addition, the occurrence of more than two consecutive
Guanines was higher in affected genes. Comparing all genes that
were significantly affected to the remaining genes gave the same
result (Table 2).
Differential expression analysis comparing tumours to
controls
As sample quality has an impact on the expression level of some
but not all genes, it is important that groups to be compared using
differential gene expression analysis include samples of the same
quality range. This restriction will ensure that the expression of a
gene is not lower or higher only because of a difference in quality
between groups. In our data, controls were of significantly better
quality. All controls except one had a Ctdiff below 5 cycles, which
was therefore used as the cut-off value for all samples and 28
tumour samples fell within this range (Figure 1). Unsupervised
hierarchical clustering of the 12579 genes significantly detected in
these 43 selected samples showed a clear separation between
tumour and control samples (Figure 5). Tumours subsequently
separated into three distinct clusters but neither gender, age of
patient, T-stage or N- stage was significantly associated with any of
the groups. Of all detected genes, 934 were found to be
significantly changed in tumours and 756 of these were
differentially expressed by more than two fold (Table S1).
Analysing the 934 changed genes using GeneGO to find over-
represented cell functions and pathways showed that the majority
of the 12 significant processes detected are important in tumour
development and maintenance (e.g. cell cycle regulation, immune
response, apoptosis, cell differentiation, vascularization and DNA
damage) (Table 3). Performing a similar analysis but including all
array samples that passed the standard quality controls (62 tumour
and 16 controls; Figure 1) resulted in a poorer separation between
tumour and control samples, where one of the controls clustered
with the tumours and two of the tumours clustered with controls.
The list of differentially expressed genes was also changed into a
longer list containing 1776 genes including for example YPEL5
and SNORA10. As can be seen in Figure 4 the difference between
tumour and control for these genes is mainly an artefact caused by
a difference in quality between tumour and control samples.
Confirmation of selected genes
Four genes from those identified using only the high quality
samples were chosen for confirmation based on their potential
importance in tumour development and progression without
previously being specifically connected to SCC of the tongue.
SLC2A6 and SLC16A3 code for transporters important for
cellular energy supply shuttling glucose and monocarboxylic acids
in and out of cells and CXCL10 is a chemokine. The precise
function of the novel protein SH3BGRL2 is unknown but it
belongs to a family of thioredoxine-like proteins [23]. All genes
showed good reproducibility when analyzing ten of the FFPE
samples using a second method, qPCR. The genes were also
analyzed in ten paired fresh frozen samples. SLC2A6, CXCL10
and SLC16A3 were significantly up-regulated and SH3BGRL2
significantly down-regulated, in agreement with the array data.
While some genes (e.g. SLC2A6, CXCL10) show a very high fold
change (.30 fold) SLC16A3 levels were only on average 1.6 fold
higher in FF SCC of the tongue (Table 4).
Discussion
Oral cancer is a relatively aggressive disease and the five year
survival of approximately 50% has not improved over the last few
decades regardless of significant improvements in surgery and
Figure 3. Linear regression analysis. Regression model describing
how much of the variation in number of detected genes on the array
can be explained by sample quality after extraction (Ctdiff).
doi:10.1371/journal.pone.0035276.g003
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regression analysis of the genes YPEL5, TRPM4 and the short non-coding gene SNORA10 describing the relationship between expression of the gene
and sample quality (CTdiff). All 78 samples are included and analysis was performed using non-normalized data. (D), (E) and (F) Linear regression
analysis of the same genes using normalized data. Samples and regression line for tumours are denoted in blue and sample and regression line for
controls in red.
doi:10.1371/journal.pone.0035276.g004
Table 2. Average number of A,C,G,T and occurrence of two or more consecutive Gs in probe sequence for the 10 most and the 10
least affected genes and p values for all affected compared to remaining genes.
Influenced genes (n=10) Non-influenced genes (n=10) p-value (20 genes)
a p-value (all genes)
a
A 10.3 10.7 0.85 0.134
C 11.3 14.1 0.04 9.9E-28
G 15.9 11.9 0.02 1.5E-30
T 12.5 13.3 0.68 0.05
$GG 4.3 2.0 0.02 2.6E-14
aMann-Whitney U test.
doi:10.1371/journal.pone.0035276.t002
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failure of treatments are two major reasons for the poor prognosis
[24,26]. Identification of novel biomarkers for early detection and
prediction of response to treatment, as well as for use as treatment
targets is of utmost importance to increase survival in this patient
group.
Transcriptional profiling has great potential in the search for
new biomarkers and treatment targets but has been limited by the
low number of fresh frozen samples available to ask specific
questions of specific cancer sub-types. With the new technologies
enabling analysis of partially degraded RNA from stored FFPE
material new possibilities are emerging [13,14]. Here, we analysed
global gene expression in FFPE sample from a subgroup of oral
cancer patients with tumours on the tongue. We, like others,
observed reasonable sensitivity with on average 52% detected
genes and very good reproducibility (r
2=0.97–0.98) using the WG
DASL assay [14,18–20]. Perhaps not surprisingly, the perfor-
mance of the arrays was dependent on the quality of the RNA and
70% of the variation in number of genes detected in a sample is
explained by the comparative amplification of a control house-
keeping mRNA (Ctdiff). A loss of signal with time and quality has
been reported before [18,27]. More worrisome was the finding
that the expression levels of individual genes were not affected
equally; the expression level of around half of the detected genes
was influenced by Ctdiff. Traditional methods for normalizing
microarray data assume that most mRNAs are affected similarly in
each sample. Our data, however, contradict this assumption for
FFPE material and indicate that current methods used to
normalize microarray data will not remove the variation caused
by a difference in quality of these samples.
The reason for non-random effects in RNA extracted from
FFPE material is likely to relate to the observations that RNA is
not only degraded in FFPE sample but is also modified. These
modifications have been shown to affect different nucleotides to
varying extents and will disrupt cDNA and PCR reactions
[11,18,28]. In addition, oxidation of nucleotides may accrue over
time and is also sequence dependent. Mittempergher et al.
previously reported a higher concordance between FFPE and FF
material for probes with a high GC content. We observed a higher
number of Cytosines in genes whose expression is least influenced
by sample quality while the number of Guanines are lower,
confirming that sequence can provide information about which
genes are more reliably detected and quantified.
Variation in RNA stability is another factor likely to be
important for individual genes being affected differently by sample
quality and has also been suggested to be partially sequence
dependent [29]. In our data, the supposedly more stable small
RNAs [30], snoRNA and miRNA, had a distinct expression
pattern as compared to longer RNAs. Whereas the expression of
most of the affected RNAs decreased with sample quality the
expression of many of the smaller RNAs increased. One possible
explanation for this could be a change in composition of total
RNA in the extract from these samples; while the more unstable
larger RNAs are lost with poorer quality the fraction of the more
stable small RNAs will increase. These results show that
identifying the genes most affected by sample storage and the
mechanisms involved in RNA degradation and modification in
FFPE samples may help improve the design of future arrays and
the development of FFPE-specific normalization steps, leading to
more sensitive analysis of global gene expression in FFPE samples.
When reducing the number of samples analyzed so that both
controls and tumours were of the same quality range we could
show that the difference between tongue tumours and control
samples produced the largest variation within the data set, as
shown in the unsupervised cluster analysis. A total of 934 genes
were significantly differentially expressed in tumours and their
biological relevance to carcinogenesis was confirmed using
pathway analysis. Not many whole genome studies on tongue
SCC have been performed previously but Ye et al. presented a 35
gene profile based on RNA from fresh frozen material [31]. In
spite of the differences in sample types and platforms used we
could confirm the majority of these genes in our data, 15 of the 17
up-regulated genes and ten of the 18 down-regulated genes. To
further confirm the validity of our data set, four genes that we
Figure 5. Dendogram from unsupervised hierarchical clustering. Including the 43 samples selected for differential gene expression analysis
and all 12579 genes detected in these samples. Control samples are denoted by C and tumours by T. Pearson correlation was used as a measurement
of similarity.
doi:10.1371/journal.pone.0035276.g005
Table 3. Pathway analysis of significant genes.
Cellular process p-Value
Immune system response 1.1E-29
Inflammatory response 9.6E-16
Tissue remodeling and wound repair 8.4E-6
Apoptosis 4.2E-5
Cell differentiation 8.1E-3
Cell cycle and its regulation 1.8E-2
Blood clotting 2.8E-2
Cystic fibrosis disease 3.1E-2
DNA-damage response 3.1E-2
Mitogenic signalling 3.2E-2
Transcription regulation 4.4E-2
Vascular development 4.9E-2
doi:10.1371/journal.pone.0035276.t003
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were confirmed in a set of fresh frozen tissues. Two of these novel
genes, SLC2A6 and SLC16A3 are membrane-bound transporters
with roles in energy metabolism. SLC2A6, also known as GLUT6,
is a member of the solute-linked carrier gene family SLC2 of
facilitative glucose transporters. GLUT6 has an ill-defined
function but has been found to be dysregulated in chronic
lymphocytic leukaemia and up-regulation of glucose transporters
has been reported in many cancer types [32,33]. SLC16A3 (also
known as MCT4) is a proton-coupled lactate transporter that is
responsible for removing excess lactate from tumour cells resulting
from their increased usage of glycolysis and recent data indicate
that MCT4 directly regulates the growth of cancer cells [33,34].
Another gene we identified is SH3BGRL2 which belongs to a
newly discovered family of thioredoxin-like proteins [23]. We
found a large down-regulation of SH3BGRL2 mRNA levels and
even though the other two family members, SH3BGRL and
SH3BGRL3, were not significantly down-regulated both showed
lower expression in tumours (21.7 and 23.2 fold respectively)
indicating that the whole family may be decreased in tumours.
Although very little is currently known about the function of these
proteins, SH3BGRL down-regulation has been shown to be
important for v-Rel-mediated transformation [35]. Finally, we
confirmed an up-regulation of the pro-inflammatory chemokine
CXCL10 which is expressed by various cancer cell types and
influences tumour progression through the recruitment of specific
immune cell types into the tumour microenvironment, and has
potential as an immunotherapeutic approach [36,37].
In conclusion, we show that analyzing FFPE samples using the
whole genome DASL array can generate highly informative results
but needs to be performed with care. Although the method is
highly reproducible, expression levels are significantly influenced
by sample quality in a manner that relates to individual RNA
probe sequences. This will impair normalization and lead to a
residual non-biological variation within the data. In order to
minimize the false detection rate and to maximize the level of
biologically relevant information obtained, samples should be of
the same quality range in groups to be compared. Thus, we
recommend that such studies be performed using only samples
that are matched for their quality following an initial qPCR
reaction and that samples with discordant results are excluded
from further analysis. In practice, this means that a larger number
of samples than ultimately required need to be screened for quality
assessment. Given the vast number of archival samples available,
this does not represent a major problem for sample acquisition. In
addition, we recommend that results are independently confirmed
at an early stage, for example by the use of qPCR on FF material
from a more limited number of samples. We show that by taking
these simple precautions gene lists obtained from FFPE material
will be of high biological relevance and we used it both for
confirming a previous result [31] as well as for making novel
findings that were confirmed in high quality fresh frozen samples.
Limitations of FFPE material can thus be reduced by careful
selection of samples with adequate quality. Given the huge
numbers of patient samples potentially available and the relative
ease of quality assessment, there is an opportunity for archival
material to identify novel pathways and biomarkers in common
and rare cancers and their subtypes.
Supporting Information
Table S1 Significantly differentially expressed genes
between cancer and control samples. Table of differentially
expressed genes from analysing the 43 selected samples. Table
includes average signal for the two groups, p values and fold
changes.
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